Treatment of DME poses

Treatment of DME poses complex choices, strives to overcome limitations Diabetic macular edema remains a major concern despite the availability of technology for potentially earlier diagnosis and better options for treatment. The 2016 WHO Global Report on Diabetes...

Top 5 predictions

Top 5 predictions in ophthalmology for 2018 By Joshua Mali, MD Editor’s Note: Welcome to “Eye Catching: Let’s Chat,” a blog series featuring contributions from members of the ophthalmic community. These blogs are an opportunity for ophthalmic bloggers to engage...

Phase II Data Support Potential for Novel

Phase II Data Support Potential for Novel Anti-VEGF/Anti-Angiopoietin-2 Bispecific Antibody, RG7716, for People With Diabetic Macular Edema RG7716 is the first bispecific antibody designed specifically for the treatment of retinal eye diseases RG7716 demonstrated...
On